NAL
Click for more information
0.00% 0.6¢ norwood abbey limited

they sold off over 1/2 of their immune technology and perhaps if...

  1. greenleaf
    3,671 Posts.
    lightbulb Created with Sketch. 210
    clock Created with Sketch.
    12/09/07
    14:00
    Post #: 2800373
    they sold off over 1/2 of their immune technology and perhaps if they sell off 1/2 needle free technology and keep going into other technology. Bit unlucky with the eye technology it has cost them dearly.
    NAL Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SXE SCEE boosts Synergy deal by $50M for Collie battery project
right-arrow Created with Sketch.
RZI https://hotcopper.com.au/news/asx-news/149063/fast-track-assaying-yields-182-g-t-gold-for-itech-at-new-nt-play/
right-arrow Created with Sketch.
ALK Alkane Resources hit 57.2Kozpa gold production through FY24 – and eyeing 70Ktpa in FY26
right-arrow Created with Sketch.
STN Saturn’s stars have aligned for the gold explorer’s Apollo Project
right-arrow Created with Sketch.
ARU Cashed up Arafura locks in $171M German export agency deal; locks in NdPr offtake for wind turbines
right-arrow Created with Sketch.
CUV British study shows Clinuvel drug effective on DNA of UV-damaged skin
right-arrow Created with Sketch.
watchlist Created with Sketch. Add NAL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.